SCHEMBL12373210

SCHEMBL12373210

CCOC(=O)c1ccc(NC(=O)CC(CN)c2ccccc2)cc1-c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.45
NPSR1 Q6W5P4 1/20 0.45
FNTA P49354 3/20 0.43
FNTB P49356 3/20 0.43
LMNA P02545 9/20 0.43
POLB P06746 2/20 0.42
TP53 P04637 3/20 0.42
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 1/20 0.42
HSD17B10 Q99714 1/20 0.42
HPGD P15428 1/20 0.41
KMT2A Q03164 2/20 0.41
GABBR2 O75899 1/20 0.40
GABBR1 Q9UBS5 1/20 0.40
SLC1A3 P43003 1/20 0.40
SLC1A2 P43004 1/20 0.40
SLC1A1 P43005 1/20 0.40
MEN1 O00255 1/20 0.40
GLA P06280 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12373216 0.91 FNTA (0.46) FNTAFNTBALDH1A1HPGDGABBR2
SCHEMBL12373215 0.86 MAPT (0.43) MAPTNPSR1FNTAFNTBLMNA
SCHEMBL2001988 0.82 RAB9A (0.57) MAPTFNTAFNTBALDH1A1KDM4E
SCHEMBL12617086 0.77 FNTA (0.45) MAPTNPSR1FNTAFNTBLMNA
SCHEMBL16221618 0.75 TDP1 (0.47) FNTAFNTBGABBR2GABBR1
SCHEMBL12373209 0.72 L3MBTL1 (0.61) MAPTNPSR1LMNAALDH1A1KDM4E
SCHEMBL1999652 0.72 MAPT (0.53) MAPTTP53ALDH1A1HSD17B10KMT2A
SCHEMBL7638409 0.71 ALDH1A1 (0.53) MAPTPOLBTP53ALDH1A1KDM4E
SCHEMBL4830396 0.70 TSHR (0.63) MAPTNPSR1LMNATP53ALDH1A1
SCHEMBL18143540 0.70 CA12 (0.62) MAPTNPSR1LMNAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110201576-A1 Small molecule inhibitors of stat3 with anti-tumor activity H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE (US) 2011-08-18 US disclosed
US-7960434-B2 Small molecule inhibitors of STAT3 with anti-tumor activity UNIVERSITY OF SOUTH FLORIDA (US) 2011-06-14 US disclosed
US-20090069420-A1 Small molecule inhibitors of STAT3 with anti-tumor activity H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE (US) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201576-A1 Small molecule inhibitors of stat3 with anti-tumor activity STAT3, STAT1, STAT5A MAPT 4441/4885NPSR1 1646/4885FNTA 2310/4885
US-20090069420-A1 Small molecule inhibitors of STAT3 with anti-tumor activity STAT3, STAT1, STAT5A MAPT 4441/4885NPSR1 1646/4885FNTA 2310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.